A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia Meeting Abstract
| Authors: | Salles, G. A.; Lamanna, N.; Amin, B. R.; Boccia, R. V.; Gabrali, N. Y.; Zaydan, M. A. A.; Wong, M.; Adewoye, A. H.; Ghia, P. |
| Abstract Title: | A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202187 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.TPS7123 |
| Notes: | Meeting Abstract: TPS7123 -- Source: Wos |
